StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.14−0.15 (-1.13%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Ascentage Pharma Group International total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ascentage Pharma Group International's total debt was CN¥1.99B at Dec 31, 2025. For fiscal 2025 it was CN¥1.99B, up 17.1% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥1.99B+17.1%
FY2024Dec 31, 2024CN¥1.70B-6.4%
FY2023Dec 31, 2023CN¥1.81B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥1.99B–
Q4 FY2024Dec 31, 2024CN¥1.70B–
Q4 FY2023Dec 31, 2023CN¥1.81B–

More Ascentage Pharma Group International figures

See a number that looks wrong?